BioSpace News Archive

Lannett Company, Inc. today announced that it is set to meet with the U.S. Food and Drug Administration on June 9, 2020 to plan next steps for the clinical advancement of its biosimilar insulin glargine partnered product candidate.

Cara Therapeutics, Inc. announced that Derek Chalmers, Ph.D., D.Sc., President and Chief Executive Officer, will participate in a fireside chat at the virtual 19th Annual Needham Healthcare Conference on Wednesday, April 15, 2020 at 10:00 a.m. ET.

BioCryst Pharmaceuticals, Inc. announced that the company will present at the 19th Annual Needham Healthcare Conference on Wednesday, April 15, 2020 at 10:00 a.m. ET.

Clearside Biomedical, Inc. announced that George Lasezkay, Pharm.D., J.D., President and Chief Executive Officer and Thomas A. Ciulla, M.D., MBA, Chief Medical Officer and Chief Development Officer will present a company overview at the Needham Virtual Healthcare Conference on April 15, 2020 at 12:00 p.m.

Nabriva Therapeutics plc announced that Ted Schroeder, Chief Executive Offer at Nabriva, will provide a company overview and business update at the 19th Annual Needham Virtual Healthcare Conference on Tuesday, April 14, at 11:20a.m. ET.

Vir Biotechnology, Inc. announced that it will host a Key Opinion Leader call and present an update on its Phase 1/2 hepatitis B virus clinical trial with small interfering ribonucleic acid VIR-2218 on Wednesday, April 15, 2020 at 2:00 pm PT.

Bio-Techne Corporation announced that management will host a conference call and webcast on Thursday, April 30, 2020, at 8:00 a.m. CDT to review third quarter 2020 financial results.

CTI BioPharma Corp. announced that management will provide a corporate overview at the Needham Healthcare Conference at 10:40 a.m. EDT.

Valens GroWorks Corp., a global leader in the end-to-end development and manufacturing of innovative, cannabinoid-based products, announced that it will begin production of hand sanitizer liquid with an initial 1,300 litre-batch at its Kelowna facility to help alleviate product supply shortages as a result of the COVID-19 health crisis.

Droplet Digital™ PCR Test Offered for Detection of SARS-CoV-2